This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: The University of Sydney. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Fadi Maged Shokry Gurgis: Innovator in Anti-Cancer Compounds
Introduction
Fadi Maged Shokry Gurgis is a notable inventor based in New South Wales, Australia. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-cancer compounds. His work focuses on creating new agents that can be used in the treatment of proliferative diseases, including brain cancer.
Latest Patents
Fadi Gurgis holds 1 patent for his innovative work on anti-cancer compounds. This patent relates to new pharmaceutical agents and their application in treating various forms of cancer. His research aims to provide effective solutions for patients suffering from these debilitating diseases.
Career Highlights
Fadi Gurgis is affiliated with the University of Sydney, where he conducts his research and development activities. His academic background and professional experience have positioned him as a key figure in the pharmaceutical industry, particularly in the area of cancer treatment.
Collaborations
Fadi has collaborated with several talented individuals in his field, including Lenka Munoz and Mia Akerfeldt. These partnerships have enhanced his research efforts and contributed to the advancement of anti-cancer therapies.
Conclusion
Fadi Maged Shokry Gurgis is a dedicated inventor whose work in anti-cancer compounds holds promise for improving treatment options for patients. His contributions to the pharmaceutical field are noteworthy and reflect his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile